Published in Cancer Weekly, October 4th, 2011
"It has been shown that the induction of p16(Ink4a) in premalignant lesions and its loss during malignant transformation is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2011-10-04)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.